title: [The first trial of azinox treatment in a clonorchiasis focus in the Socialist Republic of Vietnam].
abstract: Trials of biltricide (Merck, India) and azinox, its analog manufactured in this country, carried out in a mixed focus of clonorchiasis and intestinal nematodiases in Vietnam, have not shown any noticeable difference in the efficacy and tolerance of these drugs, that were administered for 3 days in total doses of 60 and 75 mg/kg. The mean efficacy of clonorchiasis therapy was 59.2%, and the invasion intensity reduced by more than 98%. Slight side effects were observed in 86.7% of patients.
authors.forename: T L
authors.initials: TL
authors.lastname: Kieu
authors.forename: A M
authors.initials: AM
authors.lastname: Bronshteĭn
authors.forename: T P
authors.initials: TP
authors.lastname: Sabgaĭda
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D003003:Clonorchiasis / Q000188:drug therapy*; D004197:Disease Reservoirs; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011223:Praziquantel / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013997:Time Factors; D014744:Vietnam
chemical_list: C078071:azinox; D011223:Praziquantel
vernacular_title: Pervyĭ opyt lecheniia azinoksom v ochage klonorkhoza v SRV.